Herdy Gesmar V H, Gomes Rafael S, Silva Anna E A, Silva Leandro S, Lopes Vânia G S
Departamento de Pediatria da Faculdade de Medicina, Universidade Federal Fluminense, Travessa Antonio Pedro 10/301, Niteroi, Rio de Janeiro CEP-24230030, Brazil.
Cardiol Young. 2012 Jun;22(3):263-9. doi: 10.1017/S1047951111001405. Epub 2011 Oct 21.
To present the long-term follow-up of children hospitalised for severe rheumatic carditis who were treated with corticosteroids.
This is a retrospective analysis of the outcome of 242 patients with severe rheumatic carditis after discharge from two public hospitals in Niteroi, Brazil. We followed up 118 patients for 4 years or more, with an average of 7.7 years. They were treated with antibiotics to accomplish bacterial eradication and either intravenous methylprednisolone - 40 cases - or oral prednisone - 78 patients - to treat carditis. They were followed up in outpatient clinic.
Cardiac failure was categorised as classes III and IV according to the New York Heart Association classification. In the intravenous corticosteroid group, 21 cases (52.5%) had isolated mitral valve regurgitation, 12 (30%) had mitral plus aortic involvement, and seven (17.5%) had aortic lesion only. In the oral prednisone group, 45 (58%) had mitral valve regurgitation only, 27 (34%) had mitral plus aortic involvement, and six (8%) had aortic lesion only. A total of 28 children were in their first disease attack, of whom 19 (68%) had a rupture of chordae tendineae. A total of 58 patients (49%) sustained recurrence of carditis because of neglected secondary prophylaxis. In all, 19 cases (16%) underwent cardiac surgery - valve replacement or valvuloplasty. In 33% of the cases, the outcome was favourable - asymptomatic at follow-up. The overall mortality rate was 6.8%.
Many critically ill patients who complied with secondary prophylaxis were left with minor injuries, whereas those who neglected it or abandoned it had serious sequelae. The rate of abandonment and loss to follow-up was very high. Many cases (49%) were re-hospitalised because of carditis recurrence.
介绍接受皮质类固醇治疗的因严重风湿性心脏炎住院儿童的长期随访情况。
这是一项对巴西尼泰罗伊两家公立医院242例严重风湿性心脏炎患者出院后结局的回顾性分析。我们对118例患者进行了4年或更长时间的随访,平均随访时间为7.7年。他们接受抗生素治疗以根除细菌,并使用静脉注射甲泼尼龙(40例)或口服泼尼松(78例)治疗心脏炎。在门诊对他们进行随访。
根据纽约心脏协会分类,心力衰竭被归类为III级和IV级。在静脉注射皮质类固醇组中,21例(52.5%)仅有二尖瓣反流,12例(30%)二尖瓣和主动脉均受累,7例(17.5%)仅有主动脉病变。在口服泼尼松组中,45例(58%)仅有二尖瓣反流,27例(34%)二尖瓣和主动脉均受累,6例(8%)仅有主动脉病变。共有28名儿童处于首次发病,其中19例(68%)发生腱索断裂。共有58例患者(49%)因二级预防被忽视而出现心脏炎复发。总共19例(16%)接受了心脏手术——瓣膜置换或瓣膜成形术。在33%的病例中,结局良好——随访时无症状。总死亡率为6.8%。
许多遵守二级预防的重症患者仅留下轻微损伤,而那些忽视或放弃二级预防的患者则有严重后遗症。放弃治疗和失访率非常高。许多病例(49%)因心脏炎复发而再次住院。